Abstract
The high prevalence of alcohol and drug abuse and mental illness imposes a substantial financial burden on those affected and on society. The authors present estimates of the economic costs from these causes for 1985 and 1988, based on current and reliable data available from national surveys and the use of new costing methodology. The total losses to the economy related to alcohol and drug abuse and mental illness for 1988 are estimated at $273.3 billion. The estimate includes $85.8 billion for alcohol abuse, $58.3 billion for drug abuse, and $129.3 billion for mental illness. The total estimated costs for 1985, $218.1 billion, include $51.4 billion for direct treatment and support costs; $80.8 billion for morbidity costs, the value of reduced or lost productivity; $35.8 billion for mortality costs, the value of foregone future productivity for the 140,593 premature deaths associated with these disorders, based on a 6 percent discount rate and including an imputed value for housekeeping services; and $47.5 billion in other related costs, including the costs of crime, motor vehicle crashes, fire destruction, and the value of productivity losses for victims of crime, incarceration, crime careers, and caregiver services. The cost of acquired immunodeficiency syndrome associated with drug abuse is estimated at $1 billion, and the cost of fetal alcohol syndrome is estimated at $1.6 billion. The estimates may be considered lower limits of the true costs to society of alcohol and drug abuse and mental illness in the United States.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abel E. L., Sokol R. J. Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend. 1987 Jan;19(1):51–70. doi: 10.1016/0376-8716(87)90087-1. [DOI] [PubMed] [Google Scholar]
- Cooper B. S., Rice D. P. The economic cost of illness revisited. Soc Secur Bull. 1976 Feb;39(2):21–36. [PubMed] [Google Scholar]
- Grande T. P., Wolf A. W., Schubert D. S., Patterson M. B., Brocco K. Associations among alcoholism, drug abuse, and antisocial personality: a review of literature. Psychol Rep. 1984 Oct;55(2):455–474. doi: 10.2466/pr0.1984.55.2.455. [DOI] [PubMed] [Google Scholar]
- Hilton M. E. Drinking patterns and drinking problems in 1984: results from a general population survey. Alcohol Clin Exp Res. 1987 Apr;11(2):167–175. doi: 10.1111/j.1530-0277.1987.tb01283.x. [DOI] [PubMed] [Google Scholar]
- Jolly P., Taksel L., Baime D. US medical school finances. JAMA. 1986 Sep 26;256(12):1570–1580. [PubMed] [Google Scholar]
- Kummer K., Bednash G., Redman B. Cost model for baccalaureate nursing education. J Prof Nurs. 1987 May-Jun;3(3):176–189. doi: 10.1016/s8755-7223(87)80063-7. [DOI] [PubMed] [Google Scholar]
- Regier D. A., Boyd J. H., Burke J. D., Jr, Rae D. S., Myers J. K., Kramer M., Robins L. N., George L. K., Karno M., Locke B. Z. One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry. 1988 Nov;45(11):977–986. doi: 10.1001/archpsyc.1988.01800350011002. [DOI] [PubMed] [Google Scholar]
- Regier D. A., Farmer M. E., Rae D. S., Locke B. Z., Keith S. J., Judd L. L., Goodwin F. K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990 Nov 21;264(19):2511–2518. [PubMed] [Google Scholar]
- Rice D. P., Hodgson T. A., Kopstein A. N. The economic costs of illness: a replication and update. Health Care Financ Rev. 1985 Fall;7(1):61–80. [PMC free article] [PubMed] [Google Scholar]
- Scitovsky A. A., Rice D. P. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. Public Health Rep. 1987 Jan-Feb;102(1):5–17. [PMC free article] [PubMed] [Google Scholar]
- Wolf A. W., Schubert D. S., Patterson M. B., Grande T. P., Brocco K. J., Pendleton L. Associations among major psychiatric diagnoses. J Consult Clin Psychol. 1988 Apr;56(2):292–294. doi: 10.1037//0022-006x.56.2.292. [DOI] [PubMed] [Google Scholar]